Impact of childhood traumatization and vulnerability to stress in the development of first psychotic episode

Author(s):  
Linda Rossini Gajsak
2017 ◽  
Vol 41 (S1) ◽  
pp. S277-S278
Author(s):  
L. Rossini Gajsak ◽  
M. Celic Ruzic ◽  
A. Koricancic Makar ◽  
M. Rojnic Kuzman

IntroductionSome findings in patients with first psychotic episode (FEP) could be related to alterations of stress responses. Alterations of stress response are reflected in the alterations of the HPA axis.ObjectiveTo assess the difference in stress response in FEP patients and healthy controls as well as implications of environment to vulnerability to psychosis.AimTo assess endocrine and autonomic responses to acute psychosocial stress, their associations with onset of the first psychotic episode as well as the influence of the environmental factors.MethodsWe have assessed clinical status through clinical psychiatric interviews, standardized psychiatric scales and validated psychological scales, (LEQ, WHOQOL-BREF, PBI, Rosenberg) in 45 subjects with FEP and 50 age and gender matched controls. All participants were then exposed to the Trier Social Stress Test (TSTT).ResultsOur preliminary findings on a sample of 95 participants indicate a differences between patients and controls in salivatory cortisol measured in 5 time points during the TSST. Patients with FEP experience more levels of baseline cortisole, and less changes during the stress test then controls. Baseline stress levels indicated in the salivatory cortisole levels correlate with perceived self-esteem, psychological and social quality of life.ConclusionOur findings support the alterations of stress response, possibly indicating vulnerability to stress in persons with FEP.FundingThis work was funded by the grant of the Croatian Science Foundation No UIP-2014-09-1245 Biomarkers in schizophrenia – integration of complementary methods in longitudinal follow up of first episode psychosis patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2010 ◽  
Vol 117 (2-3) ◽  
pp. 448-449
Author(s):  
Yuliya Zaytseva ◽  
Nataliya Korsakova ◽  
Isaac Gurovich ◽  
Andreas Heinz ◽  
Michael Rapp

2007 ◽  
Vol 17 ◽  
pp. S576-S577
Author(s):  
E. Del Moral ◽  
A. Palomino ◽  
C. Matute ◽  
J. Palomo ◽  
S. ´ Alvarez de Eulate ◽  
...  

2020 ◽  
Vol 13 (12) ◽  
pp. e240088
Author(s):  
Peter M Haddad ◽  
Majid Al Abdulla ◽  
Javed Latoo ◽  
Yousaf Iqbal

A 30-year-old man with no significant previous or family psychiatric history became severely anxious about his health after a positive COVID-19 test. Physical symptoms of COVID-19 were mild, with no evidence of hypoxia or pneumonia, throughout his illness. He was admitted to a quarantine facility. He remained highly anxious, and 1 week later, he developed paranoid delusions and auditory hallucinations (his first psychotic episode). He was treated with lorazepam 1 mg four times a day, mirtazapine 30 mg nocte and risperidone 1 mg two times a day. His psychotic symptoms lasted 1 week. He stopped psychiatric medication after 4 weeks and had remained well when reviewed 3 months later. A Diagnostic and Statistical Manual of Mental Disorders fifth edition diagnosis of brief psychotic disorder with marked stressor (brief reactive psychosis) was made. Anxiety about his health and social isolation appeared the main aetiological factors but an inflammatory component cannot be excluded. The case highlights that first episode psychosis can be associated with mild COVID-19.


2012 ◽  
Vol 27 ◽  
pp. 1
Author(s):  
C. Silveira ◽  
A. Norton ◽  
I. Ferraz ◽  
E. Osório ◽  
M. Fontoura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document